Baytril 2.27% Injectable Solution (20ml)

Product Description

Baytril (enrofloxacin) Injectable Solution 2.27% is a broad-spectrum fluoroquinolone indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. It has activity against both gram-negative and gram-postive bacteria, including those causing dermal, urinary and respiratory tract infections. Baytril Injectable Solution 2.27% is approved for use in dogs only.

With more than 20 years of performance, Baytril Injectable Solution 2.27% kills a broad range of disease-causing bacteria, right at the site of infection. The concentration-dependent and bactricidal soution is packaged in one 20mL vial box.